110374 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Lentivirus, not HIV, e.g. FIV, SIV Virus like particles [VLP]
P21 Expressing Monocytes for Cancer Cell Therapy
#2COMPOSITIONS FOR TREATING CANCER
#3COMPOSITIONS COMPRISING CELL LINES AND METHODS OF GENERATING VIRAL PARTICLES USING THE SAME
#4MULTIVALENT PARTICLES COMPOSITIONS AND METHODS OF USE
#5PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
#6COMPOSITIONS FOR TREATING CANCER
#7COMPOSITIONS FOR TREATING CANCER
#8ENGINEERED PNMA PROTEINS AND DELIVERY SYSTEMS THEREOF
#9METHODS AND SYSTEMS OF PARTICLE PRODUCTION
#10MODIFIED PARAMYXOVIRIDAE FUSION GLYCOPROTEINS
#11CELL-TYPE SPECIFIC MEMBRANE FUSION PROTEINS
#12ENGINEERED VIRAL PARTICLES AND USES OF THE SAME
#13COMPOSITIONS AND METHODS FOR MULTIVALENT SURFACE DISPLAY ON ENVELOPED PARTICLES
#14PSEUDOTYPED VIRAL PARTICLES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
#15VLP-based bivalent Ebola vaccines and methods of making and using same
#16Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus
#17Pseudotyped viral particles, compositions comprising the same, and uses thereof
#18VECTOR SYSTEM FOR EXPRESSING REGULATORY RNA
#19METHODS AND COMPOSITIONS FOR THE MODIFICATION AND DELIVERY OF LYMPHOCYTES
#20VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS
#21CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF
#22Method for Transduction of T Cells in the Presence of Malignant Cells
#23CHARACTERIZATION OF GENE THERAPY VIRAL PARTICLES USING SIZE EXCLUSION CHROMATOGRAPHY AND MULTI-ANGLE LIGHT SCATTERING TECHNOLOGIES
#24P21 Expressing Monocytes for Cancer Cell Therapy
#25OPTIMIZED PHENYLANANINE HYDROXYLASE EXPRESSION
#26Multivalent Virus Like Particle Vaccines
#27CRISPR SYSTEM FOR GENOME EDITING
#28Vector system for expressing regulatory RNA
#29VLP-based bivalent ebola vaccines and methods of making and using same
#30LDLR negative packaging cell line for the production of VSV-G pseudotyped retroviral vector particles or virus particles thereof
#31Use of Syncytin for Targeting Drug and Gene Delivery to Lung Tissue
#32METHODS AND COMPOSITIONS FOR TREATMENT OF HEMOPHILIA
#33Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions
#34METHODS AND COMPOSITIONS FOR THE ACTIVATION OF TUMOR CYTOTOXICITY VIA HUMAN GAMMA-DELTA T-CELLS
#35VLP-BASED MONOVALENT EBOLA VACCINES AND METHODS OF MAKING AND USING SAME
#36Retroviral and lentiviral vectors
#37METHOD FOR PREPARING VIRAL PARTICLES WITH CYCLIC DINUCLEOTIDE AND USE OF SAID PARTICLES FOR TREATING CANCER
#38Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogens
#39Lentiviral protein delivery system for RNA-guided genome editing
#40Methods and compositions for assessing viral nuclear localization
#41Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1
#42IMPROVED POLYNUCLEOTIDE SEQUENCES ENCODING TALE REPEATS
#43Lentiviral vector based immunological compounds against malaria
#44Virus-like particles, methods of preparation, and immunogenic compositions
#45Chimeric Virus Vaccines
#46Mutant tat proteins and uses thereof
#47CD40L vaccines, compositions, and methods related thereto
#48VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS
#49Lipoparticles comprising ion channels, methods of making and using the same
#50Viral deconstruction through capsid assembly in vitro
#51Virus-like particles, methods of preparation, and immunogenic compositions
#52Virus-like particles, methods of preparation, and immunogenic compositions
#53Chimeric ebola virus envelopes and uses therefor